Literature DB >> 23329068

Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.

Bari J Ballew1, Meredith Yeager, Kevin Jacobs, Neelam Giri, Joseph Boland, Laurie Burdett, Blanche P Alter, Sharon A Savage.   

Abstract

Dyskeratosis congenita (DC) is an inherited bone marrow failure and cancer predisposition syndrome caused by aberrant telomere biology. The classic triad of dysplastic nails, abnormal skin pigmentation, and oral leukoplakia is diagnostic of DC, but substantial clinical heterogeneity exists; the clinically severe variant Hoyeraal Hreidarsson syndrome (HH) also includes cerebellar hypoplasia, severe immunodeficiency, enteropathy, and intrauterine growth retardation. Germline mutations in telomere biology genes account for approximately one-half of known DC families. Using exome sequencing, we identified mutations in RTEL1, a helicase with critical telomeric functions, in two families with HH. In the first family, two siblings with HH and very short telomeres inherited a premature stop codon from their mother who has short telomeres. The proband from the second family has HH and inherited a premature stop codon in RTEL1 from his father and a missense mutation from his mother, who also has short telomeres. In addition, inheritance of only the missense mutation led to very short telomeres in the proband's brother. Targeted sequencing identified a different RTEL1 missense mutation in one additional DC proband who has bone marrow failure and short telomeres. Both missense mutations affect the helicase domain of RTEL1, and three in silico prediction algorithms suggest that they are likely deleterious. The nonsense mutations both cause truncation of the RTEL1 protein, resulting in loss of the PIP box; this may abrogate an important protein-protein interaction. These findings implicate a new telomere biology gene, RTEL1, in the etiology of DC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329068      PMCID: PMC3600110          DOI: 10.1007/s00439-013-1265-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

1.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

3.  Kaviar: an accessible system for testing SNV novelty.

Authors:  Gustavo Glusman; Juan Caballero; Denise E Mauldin; Leroy Hood; Jared C Roach
Journal:  Bioinformatics       Date:  2011-09-28       Impact factor: 6.937

4.  CTC1 Mutations in a patient with dyskeratosis congenita.

Authors:  Rachel B Keller; Katelyn E Gagne; G Naheed Usmani; George K Asdourian; David A Williams; Inga Hofmann; Suneet Agarwal
Journal:  Pediatr Blood Cancer       Date:  2012-04-24       Impact factor: 3.167

5.  RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity.

Authors:  Jean-Baptiste Vannier; Visnja Pavicic-Kaltenbrunner; Mark I R Petalcorin; Hao Ding; Simon J Boulton
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

6.  Cancer susceptibility variants and the risk of adult glioma in a US case-control study.

Authors:  Kathleen M Egan; Reid C Thompson; L B Nabors; Jeffrey J Olson; Daniel J Brat; Renato V Larocca; Steven Brem; Paul L Moots; Melissa H Madden; James E Browning; Y Ann Chen
Journal:  J Neurooncol       Date:  2011-01-04       Impact factor: 4.130

7.  Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.

Authors:  Blanche P Alter; Philip S Rosenberg; Neelam Giri; Gabriela M Baerlocher; Peter M Lansdorp; Sharon A Savage
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

Review 8.  Dyskeratosis congenita as a disorder of telomere maintenance.

Authors:  Nya D Nelson; Alison A Bertuch
Journal:  Mutat Res       Date:  2011-07-02       Impact factor: 2.433

9.  Mutations in the telomere capping complex in bone marrow failure and related syndromes.

Authors:  Amanda J Walne; Tanya Bhagat; Michael Kirwan; Cyril Gitiaux; Isabelle Desguerre; Norma Leonard; Elena Nogales; Tom Vulliamy; Inderjeet S Dokal
Journal:  Haematologica       Date:  2012-08-16       Impact factor: 9.941

10.  RTEL1 contributes to DNA replication and repair and telomere maintenance.

Authors:  Evert-Jan Uringa; Kathleen Lisaingo; Hilda A Pickett; Julie Brind'Amour; Jan-Hendrik Rohde; Alex Zelensky; Jeroen Essers; Peter M Lansdorp
Journal:  Mol Biol Cell       Date:  2012-05-16       Impact factor: 4.138

View more
  117 in total

Review 1.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

2.  Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita.

Authors:  M Brown; D Myers; N Shreve; R Rahmetullah; M Radhi
Journal:  Bone Marrow Transplant       Date:  2016-01-25       Impact factor: 5.483

Review 3.  Understanding telomere diseases through analysis of patient-derived iPS cells.

Authors:  Luis F Z Batista; Steven E Artandi
Journal:  Curr Opin Genet Dev       Date:  2013-08-28       Impact factor: 5.578

Review 4.  Applications of high-throughput DNA sequencing to benign hematology.

Authors:  Vijay G Sankaran; Patrick G Gallagher
Journal:  Blood       Date:  2013-09-10       Impact factor: 22.113

Review 5.  Telomere dynamics in mice and humans.

Authors:  Rodrigo T Calado; Bogdan Dumitriu
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

6.  Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders.

Authors:  Amany I Gorgy; Naudia L Jonassaint; Susan E Stanley; Ayman Koteish; Amy E DeZern; Jolan E Walter; Sabrina C Sopha; James P Hamilton; Julie Hoover-Fong; Allen R Chen; Robert A Anders; Ihab R Kamel; Mary Armanios
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

7.  The BUB3-BUB1 Complex Promotes Telomere DNA Replication.

Authors:  Feng Li; Hyeung Kim; Zhejian Ji; Tianpeng Zhang; Bohong Chen; Yuanlong Ge; Yang Hu; Xuyang Feng; Xin Han; Huimin Xu; Youwei Zhang; Hongtao Yu; Dan Liu; Wenbin Ma; Zhou Songyang
Journal:  Mol Cell       Date:  2018-05-03       Impact factor: 17.970

8.  Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Authors:  Jialin Xu; Payal P Khincha; Neelam Giri; Blanche P Alter; Sharon A Savage; Judy M Y Wong
Journal:  Am J Hematol       Date:  2016-11-04       Impact factor: 10.047

9.  A homozygous telomerase T-motif variant resulting in markedly reduced repeat addition processivity in siblings with Hoyeraal Hreidarsson syndrome.

Authors:  Maria M Gramatges; Xiaodong Qi; Ghadir S Sasa; Julian J-L Chen; Alison A Bertuch
Journal:  Blood       Date:  2013-03-28       Impact factor: 22.113

Review 10.  Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.

Authors:  Allison H West; Lucy A Godley; Jane E Churpek
Journal:  Ann N Y Acad Sci       Date:  2014-01-27       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.